The £13m drug discovery partnership of Oxford University, Evotec and Oxford Sciences Innovation targets five new life sciences projects for acceleration.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
As of 2015, OUI has helped create 136 high tech companies based on University intellectual property with a combined turnover of £600m a year, providing 1,886 jobs and adding £132m a year to the local economy.
Scenic Biotech’s ‘genetic off-switch’ for disease secures major investment to accelerate development
Scenic Biotech, an international collaboration between Oxford University and Netherlands Cancer Institute, aims to unlock genetic potential in tackling cancer and other diseases with new funding.
Colwiz, a 2013 OUI Incubator company, and Oxford Gene Technology, a spinout 20 years in the making, both make successful trade sales.
Roundup of news, deals, and data from OUI for Q1 2017.
Oxford University and Evotec’s drug discovery partnership launched last year to quickly accelerate drugs to market begins making awards.
Oxford spinout Celleron Therapeutics raises funding from South Korean consortium of investors for small molecule treatments.
OxSonics, an Oxford University spinout established in 2013 to develop ultrasound therapeutics, has secured £9.4m in series B equity financing, bringing its total external fundraising to £14.2m.
Oxford University Innovation launches 24 companies in 2016 with a combined £52.6m in early stage funding, setting a new record in spinout generation for the UK and Europe.